首页    期刊浏览 2024年11月29日 星期五
登录注册

文章基本信息

  • 标题:Angelica keiskei Ameliorates Scopolamine-Induced Memory Impairments in Mice
  • 本地全文:下载
  • 作者:Sa Rang Oh ; Su-Jin Kim ; Dong Hyun Kim
  • 期刊名称:Biological and Pharmaceutical Bulletin
  • 印刷版ISSN:0918-6158
  • 电子版ISSN:1347-5215
  • 出版年度:2013
  • 卷号:36
  • 期号:1
  • 页码:82-88
  • DOI:10.1248/bpb.b12-00681
  • 出版社:The Pharmaceutical Society of Japan
  • 摘要:Memory impairment is the most common symptom in patients with Alzheimer’s disease (AD). Angelica keiskei (AK) has traditionally been used as a diuretic, laxative, analeptic and galactagogue. However, the anti-amnesic effects of AK and its molecular mechanisms have yet to be clearly elucidated. The aim of the present study is to evaluate the effects of AK on scopolamine-induced memory impairments in mice. The regulatory effect of AK on memory impairment was investigated using passive avoidance, Y-maze and the Morris water maze tasks. Acetylcholinesterase (AChE) activity assay was performed to investigate the cholinergic antagonistic effect of AK in the hippocampus. The effect of AK on phosphorylation of cAMP response element-binding protein (CREB) and expression of brain-derived neurotrophic factor (BDNF) were evaluated by Western blot assays and immunohistochemistry. The findings showed that AK significantly attenuated scopolamine-induced cognitive impairment in mice. Increase of AChE activity caused by scopolamine was significantly attenuated by AK. Additionally, AK significantly recovered the phosphorylation of CREB and expression of BDNF reduced by scopolamine in the hippocampus. Taken together, these results provide experimental evidence that AK might be a useful agent in preventing deficit of learning and memory caused by AD and aging.
  • 关键词:Angelica keiskei; memory impairment;scopolamine;acetylcholinesterase;cAMP response element-binding protein;brain-derived neurotrophic factor
国家哲学社会科学文献中心版权所有